|
Apr 28, 2026 |
Fund Letters |
Polen Capital - Global Growth |
Novo Nordisk
|
Health Care |
Pharmaceuticals |
Bull
|
NYSE |
Denmark, Diabetes, GLP-1, healthcare innovation, obesity treatment, pharmaceuticals, secular growth |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
Polen Capital - Global Growth |
Novo Nordisk A/S
|
Health Care |
Pharmaceuticals |
Bull
|
NASDAQ |
Blockbuster Drugs, Denmark, Diabetes, GLP-1, healthcare innovation, Obesity, pharmaceuticals |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
Polen Capital - International Growth |
Novo Nordisk
|
Health Care |
Pharmaceuticals |
Bull
|
NYSE |
Denmark, Diabetes, GLP-1 drugs, Metabolic Diseases, Obesity, Ozempic, pharmaceuticals, Wegovy |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
Wedgewood Partners |
O'Reilly Automotive
|
Consumer Discretionary |
Automotive Retail |
Bull
|
NASDAQ |
Automotive Aftermarket, DIFM, distribution network, DIY, market share, retailer, ROIC, Share Buybacks |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
TimesSquare Capital Management U.S. FOCUS Growth Equity strategy |
CrowdStrike Holdings Inc.
|
Software & Services |
Systems Software |
Bull
|
NASDAQ |
ARR growth, Cloud software, cybersecurity, endpoint protection, IT Security, SaaS |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
TimesSquare Capital Management U.S. FOCUS Growth Equity strategy |
CrowdStrike Holdings Inc.
|
Information Technology |
Systems Software |
Bull
|
NASDAQ |
cloud security, cybersecurity, endpoint protection, growth, SaaS, SIEM, technology |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
Brown Capital Management International All Company Fund |
Novo Nordisk
|
Health Care |
Pharmaceuticals |
Bull
|
NYSE |
Biotech, Denmark, Diabetes, GLP-1, market leader, obesity treatment, Ozempic, pharmaceuticals, Wegovy |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
The Wolf of Harcourt Street |
BYD Company Limited
|
Consumer Discretionary |
Automobiles |
Bull
|
HKEX |
automotive, battery technology, China, Cost advantage, Electric Vehicles, growth, Value, vertical integration |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
Torre Financial |
O'Reilly Automotive
|
Consumer Discretionary |
Specialty Retail |
Bull
|
NASDAQ |
aftermarket, Antifragile, automotive, Defensive growth, distribution network, DIY, high-ROIC, market share gains, negative working capital, Parts Distribution, professional services, Specialty retail |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
PM Capital Global Companies Fund |
BYD Company Limited
|
Consumer Discretionary |
Automobiles |
Bull
|
HKEX |
automotive, Batteries, China, Cost advantage, Electric Vehicles, global expansion, growth, vertical integration |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
Spree Capital Advisers |
CrowdStrike Holdings Inc
|
Software & Services |
Systems Software |
Bull
|
NASDAQ |
cloud-native, cybersecurity, Enterprise software, growth, platform, SaaS, technology |
View Pitch |
|
Apr 28, 2026 |
Fund Letters |
Centerstone Investors Fund |
O'Reilly Automotive
|
Consumer Discretionary |
Automotive Retail |
Bull
|
NASDAQ |
Aging Vehicle Fleet, Automotive Aftermarket, Distribution Infrastructure, Dual Market Strategy, market leader, market share gains, Non-Discretionary, Professional Pricing |
View Pitch |
|
Apr 27, 2026 |
Fund Letters |
Evolve Private Wealth |
Novo Nordisk A/S
|
Health Care |
Pharmaceuticals |
Bear
|
NASDAQ |
CEO transition, Compounded Drugs, diabetes treatment, GLP-1, Market Slowdown, Pharmaceutical Competition, Profit Warning, semaglutide |
View Pitch |